On-demand
Self-paced
1 hour (online)
CE
Free
This online, self-paced, text-based module educates healthcare professionals towards a better understanding of the benefits and limitations of direct-to-consumer pharmacogenomic testing, when to pursue confirmatory clinical testing, and how to interpret pharmacogenomic test results using evidence-based resources.
It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG).
To access, log in to our site (to right of this page; free registration) and enroll using one of the following methods:
- Free for all learners (via self-enrollment below)
- For continuing education credit (requires small fee; click 'Pay Now' below)
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series:
- Philip Empey, PharmD, PhD, FCCP (University of Pittsburgh School of Pharmacy)
- Andrew Monte, MD, PhD (University of Colorado)
- Trina Walker, DNP, APRN, FNP-C (Creighton University)
- Nguyen Park, MS, PA-C (National Human Genome Research Institute)
- Jeneva Gularte-Rinaldo, PhD, RN (Samuel Merritt University)
Course Directors
|
Roseann S. Donnelly (Gammal), PharmD, BCPS Associate Professor Massachusetts College of Pharmacy and Health Sciences
|
Additional Content Reviewers
- Cyrine-Eliana Haidar, PharmD, BCPS, BCOP, FASHP, Clinical Pharmacogenetics Coordinator, St. Jude Children’s Research Hospital
- David Kisor, PharmD, FCP, Professor of Pharmaceutical Sciences and Pharmacogenomics, Manchester University
TARGET AUDIENCE
All healthcare professionals
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Differentiate between the delivery models for pharmacogenomic testing.
- Identify the benefits and limitations of direct-to-consumer (DTC) pharmacogenomic testing.
- Interpret DTC pharmacogenomic test results.
- Evaluate the clinical actionability of genetic variants detected by a DTC pharmacogenomic test using evidence-based resources.
- Determine when confirmatory clinical testing is needed when faced with DTC pharmacogenomic test results.
- Explain why confirmatory clinical pharmacogenomic test results may differ from direct-to-consumer pharmacogenomic test results for the same patient.
- Discuss issues related to documenting DTC pharmacogenomic test results in the electronic health record.
DISCLAIMER STATEMENT
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Released 08/15/2023, Expires 08/15/2026
ACCREDITATION
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
HOW TO OBTAIN CONTINUING EDUCATION
Continuing education is available for the above learner groups for a small processing fee. Please register for the course using the 'Pay Now' button below. Once you complete the course, the "If requesting continuing education (paid users only)" instructions will unlock automatically with further instructions.